Device recall · March 22, 2023
BD Ultra-Fine Insulin Syringe 0.5mL recall
Why: Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
BD Ultra-Fine Insulin Syringe 0.5mL, 8mm, 31G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326713
- Lots / codes
GTIN: N/A Lot Number: 2038580, Exp. Date: 20270531; Lot Number: 2063298, Exp. Date: 20270531; Lot Number: 2137904, Exp. Date: 20270731
- Quantity
- 1,129,000 units
- Company
- Becton Dickinson & Company, Franklin Lakes, NJ
- Distribution
- Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.
- Initiated
- February 1, 2023 · Voluntary: Firm initiated
- Classified
- March 10, 2023
- Reported
- March 22, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.